Skip to main content

Table 1 CRRT prescription details

From: Effects of continuous renal replacement therapy with the AN69ST membrane for septic shock and sepsis-induced AKI in an infant: a case report with literature review of cytokine/mediator removal therapy in children

Patient’s body weight

4.2 kg

Mode

CHD

Console

ACH-Σ ® (Asahi Kasei Medical, Tokyo, Japan)

Column

sepXiris® 60 (Baxter International, Chicago, IL), surface area: 0.6 m2, priming volume: 47 mL

Circuit

CHDF-PSG® (Asahi Kasei Medical, Tokyo, Japan)

Total priming volume

90 mL

Priming solution

Packed red blood cells and fresh frozen plasma mixed in a 2:1 ratio

Anticoagulant

Nafamostat mesilate (Futhan®;Torii Pharmaceutical, Tokyo, Japan), dose: 0.5–1 mg/kg/h*

Blood flow rate (Qb), mL/min

10-15

Dialysate flow rate (Qd), mL/h

1200-1800

Replacement fluid (mEq/L)

Na+: 140

K+: 2.0

Ca2+: 3.5

Mg2+: 1.0

Cl: 113

HCO3: 35

  1. Abbreviations: CRRT continuous renal replacement therapy, CHD continuous hemodialysis
  2. *Maintain activated coagulation time (ACT) between 150 s and 200 s